Ashton Thomas Securities
HQL icon

Ashton Thomas Securities’s abrdn Life Sciences Investors HQL Stock Holding History

Ashton Thomas Securities’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$242K Buy
+12,933
New +$262K 0.03% 348
2024
Q4 		– Sell
-9,817
Closed -$148K – 669
2024
Q3 		$148K Buy
+9,817
New +$149K 0.03% 289

Other funds holding HQL

Flagship Harbor Advisors
Flagship Harbor Advisors Boston, Massachusetts $2.69B AUM 15.82% 1-Year Est. Return
Blue Bell Private Wealth Management
Blue Bell Private Wealth Management Blue Bell, Pennsylvania $840M AUM 13.7% 1-Year Est. Return
PMG Family Office
PMG Family Office Plano, Texas $108M AUM 8.93% 1-Year Est. Return
KPP Advisory Services
KPP Advisory Services Louisville, Kentucky $594M AUM 20.44% 1-Year Est. Return
Wedbush Securities
Wedbush Securities Los Angeles, California $3.95B AUM 25.45% 1-Year Est. Return
Oppenheimer & Co
Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return
Decision Investments
Decision Investments San Diego, California $110M AUM 52.83% 1-Year Est. Return
Independent Financial Group
Independent Financial Group San Diego, California $5.51B AUM 33.51% 1-Year Est. Return
Wealthcare Advisory Partners
Wealthcare Advisory Partners West Chester, Pennsylvania $5.9B AUM 14.62% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Ashton Thomas Securities's HQL Position: Q3 2026 in Review

Ashton Thomas Securities opened a new position in abrdn Life Sciences Investors (HQL) in Q3 2026: 12,933 shares worth $242K. The stake represents 0.03% of the portfolio and ranks #348 among its holdings. This is a return to the name: Ashton Thomas Securities previously reported a position in HQL as recently as Q3 2024.

Ashton Thomas Securities first reported a position in HQL in Q3 2024 and has held it in 2 quarters since. 22 funds tracked by Wall St. Rank hold HQL as of Q3 2026.

  • Ashton Thomas Securities held 12,933 shares of abrdn Life Sciences Investors worth $242K as of Q3 2026.
  • abrdn Life Sciences Investors was a new Ashton Thomas Securities position in Q3 2026.
  • abrdn Life Sciences Investors made up 0.03% of Ashton Thomas Securities's portfolio in Q3 2026, its #348 holding.
  • Ashton Thomas Securities first reported a position in abrdn Life Sciences Investors in Q3 2024 and has held it in 2 quarters since.
  • 22 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2026.

Based on Ashton Thomas Securities's 13F filing for Q3 2026, filed 26 Oct 2026.